Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS EQUITY (Narrative) (Details)

v3.22.4
STOCKHOLDERS EQUITY (Narrative) (Details) - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 9 Months Ended
Mar. 04, 2022
May 12, 2021
Nov. 23, 2022
Nov. 16, 2022
Aug. 29, 2022
Jul. 25, 2022
Sep. 29, 2022
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2022
Oct. 07, 2013
Stockholders Equity Note [Line Items]                                  
Preferred stock, shares authorized               100,000,000           100,000,000   100,000,000 100,000,000
Aggregate cash payments   $ 3,000,000                              
Additional aggregate cash payments               $ 1,750,000           $ 1,750,000      
Aggregate cash payments for fiscal year 2023               250,000           250,000      
Aggregate cash payments for fiscal year 2024               250,000           250,000      
Dividend payable               5,500           5,500      
Stock compensation expense               806,758           2,420,273      
Stock compensation expense in quarter ended December 31, 2022                           806,758      
Stock compensation expense in quarter ended March 31, 2023                           806,758      
Total stock compensation expense for year ended March 31, 2023               3,227,030           3,227,030      
Stock compensation expense for years ended March 31, 2024               3,227,030           3,227,030      
Stock compensation expense years ended March 31, 2025               185,586           185,586      
Value of common stock shares issued upon conversion                   $ 2,227,030              
Aggregate gross proceeds         $ 1,051,428                 5,268,592 $ 4,995,250    
Discount on preferred stock               193,847           193,847   $ 0  
Convertible notes, aggregate principal amount               0           0   $ 2,223,633  
Exercise price of warrants         $ 0.46                        
Stock Issued During Period, Value, New Issues                   5,268,592   $ 4,995,250          
Amortization of debt discount                           1,598,855 0    
Value of restricted shares granted               791,035 $ 386,072 $ 222,017 $ 3,093,350 $ 625,556 $ 651,648        
Common shares issued upon exercise of warrants (Shares)             2,285,714                    
Exercise price of warrants exercised         0.46                        
Proceeds from warrants exercised             $ 1,051,428             5,653,544 $ 13,390,313    
Warrants exercised during period, original exercise price         $ 1.25                        
Series S Preferred Stock [Member]                                  
Stockholders Equity Note [Line Items]                                  
Value of common stock shares issued upon conversion   $ 6,681,090                              
Price per share   $ 1                              
Number of common stock shares issued upon conversion   6,681,090                              
Vesting of stock recognized as prepaid expense   $ 2,227,030                              
Expenses related to stock               556,758           1,670,273      
Series E Preferred Stock [Member]                                  
Stockholders Equity Note [Line Items]                                  
Share price     $ 1                            
Number of shares issued     1,100,000                            
Percentage of stated value per share     6.00%                            
Aggregate gross proceeds     $ 1,100,000                            
Description of ownership limitation     The conversion right is subject to the beneficial ownership limitation, which will be 4.99% of the number of shares of our common stock outstanding immediately after giving effect to the issuance of shares of our common stock issuable upon conversion of the Series E Preferred Stock held by the applicable Holder. The Holder may increase or decrease the beneficial ownership limitation upon not less than 61 days' prior notice to our company, but in no event will such beneficial ownership exceed 9.99%.                            
Debt settlement price per share     $ 0.25                            
Value of warrants issued     $ 211,470                            
Value of common stock issued     $ 888,530                            
Price per share     $ 1                            
Private Placement [Member]                                  
Stockholders Equity Note [Line Items]                                  
Convertible notes, aggregate principal amount $ 3,800,000                                
Notes maturity, description The Notes were to mature on September 4, 2022                                
Debt, accrue interest rate per annum 8.00%                                
Debt conversion price $ 0.8                                
Subscription Agreement [Member]                                  
Stockholders Equity Note [Line Items]                                  
Number of shares issued 475,000                                
Debt discount $ 345,455                                
Amortization of debt discount               121,619           294,346      
Subscription Agreement [Member] | Series E Preferred Stock [Member]                                  
Stockholders Equity Note [Line Items]                                  
Share price     $ 0.25                            
Number of shares issued     880,000                            
Debt Settlement Agreement [Member]                                  
Stockholders Equity Note [Line Items]                                  
Number of shares issued           10,459,354                      
Convertible debt aggregate amount           $ 3,869,962                      
Convertible debt, principal amount           3,800,000                      
Accrued and unpaid interest           $ 69,962                      
Debt settlement price per share           $ 0.37                      
Debt conversion price           0.8                      
Price per share           $ 0.429                      
Non-cash inducement interest expense           $ 2,405,612                      
Warrant [Member]                                  
Stockholders Equity Note [Line Items]                                  
Beneficial conversion feature $ 1,524,750             $ 542,133           $ 1,304,508      
Number of shares issued           10,459,354                      
Price per share           $ 1.1                      
Number of warrants issued to purchase of common stock           10,459,354                      
Proceeds from issuance of warrants           $ 4,602,116                      
Common Stock [Member]                                  
Stockholders Equity Note [Line Items]                                  
Stock option and RSU-related compensation expense and common shares issued upon conversion of RSUs (in shares)               1,225,000 500,000 221,665              
Value of common stock shares issued upon conversion                   $ 2,227              
Number of common stock shares issued upon conversion                   2,227,030              
Stock Issued During Period, Shares, New Issues                   9,083,574   4,757,381          
Stock Issued During Period, Value, New Issues                   $ 9,083   $ 4,757          
Value of restricted shares granted               $ 1,225 $ 500 $ 222              
Common shares issued upon exercise of warrants (Shares)                 12,745,068   666,667 9,523,376 1,277,777        
2020 Equity Incentive Plan [Member]                                  
Stockholders Equity Note [Line Items]                                  
Stock option and RSU-related compensation expense and common shares issued upon conversion of RSUs (in shares)       2,550,000                          
Description of restricted awards       (i) 2,450,000 vest as to 50% on the grant date and 50% on the six month anniversary of the grant date; and (ii) 100,000 vest as to 50% on the six month anniversary of the grant date and 50% on the one year anniversary of the grant date.                          
Klutch Financial Corp. [Member]                                  
Stockholders Equity Note [Line Items]                                  
Aggregate gross proceeds         $ 460,000                        
Proceeds from warrants exercised         $ 460,000                        
Warrants exercised during period, original exercise price         $ 1,000,000                        
Maximum [Member] | Warrant [Member]                                  
Stockholders Equity Note [Line Items]                                  
Exercise price of warrants           $ 1.1                      
Minimum [Member] | Warrant [Member]                                  
Stockholders Equity Note [Line Items]                                  
Exercise price of warrants           $ 0.44